Latest & greatest articles for finasteride

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on finasteride or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on finasteride and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for finasteride

1. Finasteride

Finasteride Top results for finasteride - Trip Database or use your Google+ account Liberating the literature ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2) and (#3 (...) or #4) Loading history... Population: Intervention: Comparison: Outcome: Population: Intervention: Latest & greatest articles for finasteride The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence

2018 Trip Latest and Greatest

2. COMPARISON OF FINASTERIDE, METFORMIN, AND FINASTERIDE PLUS METFORMIN IN PCOS. Full Text available with Trip Pro

COMPARISON OF FINASTERIDE, METFORMIN, AND FINASTERIDE PLUS METFORMIN IN PCOS. The effects of finasteride on insulin resistance and of metformin on hyperandrogenism in patients with polycystic ovary syndrome (PCOS) are not clear. This study therefore compared the effects of finasteride, metformin, and finasteride plus metformin treatments on hormone levels, insulin resistance, and hirsutism score in women with PCOS. Fifty-two patients with PCOS were randomly assigned to receive finasteride 5 mg (...) /day, metformin 1700 mg/day or finasteride plus metformin for 12 months. Body mass index (BMI), Ferriman Gallway score (FGS), serum concentrations of estradiol, sex hormone-binding globulin, free testosterone, dehydroepiandrosterone sulfate (DHEAS), androstenedione, and homeostasis model assessment of insulin resistance (HOMA-IR) index and areas under the curve (AUC) for insulin and glucose were evaluated before and after 12 months of treatment. Reductions in FGS, free testosterone, DHEAS

2019 Acta endocrinologica (Bucharest, Romania : 2005) Controlled trial quality: uncertain

3. Finasteride and Androgenic Alopecia; from Therapeutic Options to Medical Implications. (Abstract)

Finasteride and Androgenic Alopecia; from Therapeutic Options to Medical Implications. Androgenic alopecia (AGA) is an esthetic condition with varying psycho-social implications, easily accepted by some patients and tolerated only with difficulty by others. Modern therapeutic options such as 5α-reductase inhibitors have significant outcomes, but also exert significant side effects in a subset of patients. The literature describes three distinct situations regarding finasteride administration (...) , a compound largely used for AGA. Some studies show finasteride to be very safe with minimal or no side effects. Other studies take a more cautious approach, recognizing such side effects but, at the same time, considering the putative relationship between finasteride and adverse effects to be disputable, given that placebo administration in AGA is associated with relatively similar or even more severe side effects. Finally, some authors/studies are concerned that, when compared to placebo, finasteride

2019 Journal of Dermatological Treatment

4. Dutasteride and Finasteride for Men with Benign Prostatic Hyperplasia

Dutasteride and Finasteride for Men with Benign Prostatic Hyperplasia TITLE: Dutasteride and Finasteride for Men with Benign Prostatic Hyperplasia: Comparative Clinical Effectiveness and Safety DATE: 07 March 2014 RESEARCH QUESTIONS 1. What is the comparative clinical effectiveness and safety of dutasteride and finasteride for men with benign prostatic hyperplasia? 2. What is the clinical effectiveness and safety of dutasteride versus placebo for men with benign prostatic hyperplasia? 3. What (...) is the clinical effectiveness and safety of finasteride versus placebo for men with benign prostatic hyperplasia? KEY MESSAGE Four systematic reviews and six randomized controlled trials were found regarding the clinical effectiveness and safety of dutasteride and finasteride compared to each other or placebo for the treatment of benign prostatic hyperplasia. METHODS A limited literature search was conducted on key resources including PubMed, The Cochrane Library (2014, Issue 2), University of York Centre

2014 Canadian Agency for Drugs and Technologies in Health - Rapid Review

5. Alopecia, androgenetic - male: Finasteride

Alopecia, androgenetic - male: Finasteride Finasteride | Prescribing information | Alopecia, androgenetic - male | CKS | NICE Search CKS… Menu Finasteride Alopecia, androgenetic - male: Finasteride Last revised in July 2018 Finasteride Finasteride 1 mg tablets (Propecia®) are not available to prescribe on the NHS, but can be prescribed on a private prescription. Finasteride 1 mg tablets are a prescription-only medicine and cannot be purchased over-the-counter. However, in some areas (...) , they are available to purchase from a pharmacy under local Patient Group Directive (PGD) arrangements. [ ; ] What are the contraindications and cautions for finasteride? Finasteride should be avoided in men who: Are hypersensitive to finasteride. Have severe liver disease. Finasteride should be used with caution in men who: Have mild to moderate liver disease. Have obstructive uropathy. Have a female partner. Women of childbearing potential whose male partner is taking oral finasteride, should avoid handling

2016 NICE Clinical Knowledge Summaries

6. Efficacy of Topical Combination of 0.25% Finasteride and 3% Minoxidil Versus 3% Minoxidil Solution in Female Pattern Hair Loss: A Randomized, Double-Blind, Controlled Study. (Abstract)

Efficacy of Topical Combination of 0.25% Finasteride and 3% Minoxidil Versus 3% Minoxidil Solution in Female Pattern Hair Loss: A Randomized, Double-Blind, Controlled Study. The relationship between female pattern hair loss (FPHL) and androgenic hormones is not well established, but some evidence indicates oral finasteride may be efficacious in FPHL. Use of a topical formulation has been proposed to minimize unwanted effects.Our objective was to compare the efficacy and safety of topical 0.25 (...) % finasteride combined with 3% minoxidil solution and 3% minoxidil solution as monotherapy in the treatment of FPHL.This was a prospective, randomized, double-blind study in 30 postmenopausal women with FPHL. Each participant was randomized to receive either topical 0.25% finasteride combined with topical 3% minoxidil or topical 3% minoxidil solution as monotherapy for 24 weeks. To determine efficacy, the hair density and diameter was measured and global photographic assessment was conducted at baseline

2018 American journal of clinical dermatology Controlled trial quality: predicted high

7. Superiority of dutasteride over finasteride in hair regrowth and reversal of miniaturization in men with androgenetic alopecia: A randomized controlled open-label, evaluator-blinded study. Full Text available with Trip Pro

Superiority of dutasteride over finasteride in hair regrowth and reversal of miniaturization in men with androgenetic alopecia: A randomized controlled open-label, evaluator-blinded study. Finasteride and dutasteride are inhibitors of the enzyme 5-alpha-reductase which inhibits the conversion of testosterone to dihydrotestosterone. Dutasteride inhibits both type I and type II 5-alpha-reductase while finasteride inhibits only the type II enzyme. As both isoenzymes are present in hair follicles (...) , it is likely that dutasteride is more effective than finasteride.To compare the efficacy, safety and tolerability of dutasteride and finasteride in men with androgenetic alopecia.Men with androgenetic alopecia between 18 and 40 years of age were randomized to receive 0.5 mg dutasteride or 1 mg finasteride daily for 24 weeks. The primary efficacy variables were hair counts (thick and thin) in the target area from modified phototrichograms and global photography evaluation by blinded and non-blinded

2016 Indian journal of dermatology, venereology and leprology Controlled trial quality: uncertain

8. Comparitive effectiveness of finasteride vs Serenoa repens in male androgenetic alopecia: a two-year study. (Abstract)

Comparitive effectiveness of finasteride vs Serenoa repens in male androgenetic alopecia: a two-year study. The objective of this open label study is to determine the effectiveness of Serenoa repens in treating male androgenetic alopecia (AGA), by comparing its results with finasteride. For this purpose, we enrolled 100 male patients with clinically diagnosed mild to moderate AGA. One group received Serenoa repens 320 mg every day for 24 months, while the other received finasteride 1 mg every (...) day for the same period. In order to assess the efficacy of the treatments, a score index based on the comparison of the global photos taken at the beginning (T0) and at the end (T24) of the treatment, was used. The results showed that only 38% of patients treated with Serenoa repens had an increase in hair growth, while 68% of those treated with finasteride noted an improvement. Moreover finasteride was more effective for more than half of the patients (33 of 50, i.e. 66%

2013 International journal of immunopathology and pharmacology Controlled trial quality: uncertain

9. 71 years old gentleman with symptoms of lower urinary tract obstruction. He is also known to have high blood pressure controlled on treatment. For his urinary symptoms he is on Finasteride which was

71 years old gentleman with symptoms of lower urinary tract obstruction. He is also known to have high blood pressure controlled on treatment. For his urinary symptoms he is on Finasteride which was 71 years old gentleman with symptoms of lower urinary tract obstruction. He is also known to have high blood pressure controlled on treatment. For his urinary symptoms he is on Finasteride which was worked initially but currently is not as effective. He was seen by Urologist in the past (...) across other content types including images, videos, patient information leaflets, educational courses and news. For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com 71 years old gentleman with symptoms of lower urinary tract obstruction. He is also known to have high blood pressure controlled on treatment. For his urinary symptoms he is on Finasteride which

2011 TRIP Answers

10. Platelet-Rich Plasma in Combination With 5% Minoxidil Topical Solution and 1 mg Oral Finasteride for the Treatment of Androgenetic Alopecia: A Randomized Placebo-Controlled, Double-Blind, Half-Head Study. (Abstract)

Platelet-Rich Plasma in Combination With 5% Minoxidil Topical Solution and 1 mg Oral Finasteride for the Treatment of Androgenetic Alopecia: A Randomized Placebo-Controlled, Double-Blind, Half-Head Study. 28562433 2018 05 03 2018 05 03 1524-4725 44 1 2018 Jan Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] Dermatol Surg Platelet-Rich Plasma in Combination With 5% Minoxidil Topical Solution and 1 mg Oral Finasteride for the Treatment (...) of Androgenetic Alopecia: A Randomized Placebo-Controlled, Double-Blind, Half-Head Study. 126-130 10.1097/DSS.0000000000001198 Alves Rubina R Department of Dermatology, Universitat Internacional de Catalunya, Barcelona, Spain. Grimalt Ramon R eng Letter Randomized Controlled Trial United States Dermatol Surg 9504371 1076-0512 0 Angiogenesis Inducing Agents 57GNO57U7G Finasteride 5965120SH1 Minoxidil IM Administration, Topical Alopecia drug therapy Angiogenesis Inducing Agents administration & dosage Double

2018 Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] Controlled trial quality: uncertain

11. A systematic review of Autologous Platelet-Rich Plasma (PRP) use in Androgenetic Alopecia (AGA) compared with Minoxidil?, Finasteride? and Adult Stem Cells Based Therapy (ASCs-BT)

A systematic review of Autologous Platelet-Rich Plasma (PRP) use in Androgenetic Alopecia (AGA) compared with Minoxidil?, Finasteride? and Adult Stem Cells Based Therapy (ASCs-BT) Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility

2020 PROSPERO

12. Drug Treatment for Androgenetic Alopecia: First Italian Questionnaire Survey on What Dermatologists Think about Finasteride Full Text available with Trip Pro

Drug Treatment for Androgenetic Alopecia: First Italian Questionnaire Survey on What Dermatologists Think about Finasteride Treatment with finasteride 1 mg/day represents the therapy of choice for androgenetic alopecia (AGA). We investigated how Italian dermatologists approach use of finasteride for treatment of AGA and common side effects reported by patients.A tablet-based survey was conducted from February 2017 to January 2018 in Italy to investigating use of 1 mg/day finasteride (...) in the treatment of AGA. Approximately 1153 Italian dermatologists were surveyed about prescription frequency, therapy duration, treatment practices, and side effects eventually reported.Dermatologists considered treatment with 1 mg/day finasteride to be the most efficacious treatment for AGA, as reflecting by its long-term (5 years) prescription. Data on sexual side effects from our survey are in line with previous scientific evidence, especially regarding loss of libido, erectile dysfunction, and problems

2018 Dermatology and therapy

13. A Review of the FAERS Data on 5-Alpha Reductase Inhibitors: Implications for Post-Finasteride Syndrome. (Abstract)

A Review of the FAERS Data on 5-Alpha Reductase Inhibitors: Implications for Post-Finasteride Syndrome. To quantify reports made to the Food and Drug Administration Adverse Event Reporting System (FAERS), create a demographic of patient reports, and examine the cluster of symptoms to correlate consistency of postfinasteride syndrome (PFS) complaints. PFS is a provisional diagnosis encompassing a cluster of sexual, physical, and psychological and/or neurologic symptoms associated with 5-alpha (...) reductase inhibitor use that emerge or continue after discontinuation of medication.FAERS dataset of 5-alpha reductase inhibitors from April 2011 to October 2014 was obtained. Each FAERS report had 16 categories for completion, but not every report was fully completed. Statistical analysis compared variables of interest between the 2 doses of finasteride (1 mg vs 5 mg).From FAERS, 2048 monotherapy cases were identified: 1581 of finasteride 1 mg, 240 of finasteride 5 mg, and 226 of unreported doses

2018 Urology

14. Combined treatment with oral finasteride and topical minoxidil in male androgenetic alopecia: a randomized and comparative study in Chinese patients. Full Text available with Trip Pro

Combined treatment with oral finasteride and topical minoxidil in male androgenetic alopecia: a randomized and comparative study in Chinese patients. Finasteride at 1 mg/day and 5% topical minoxidil are effective in male androgenetic alopecia (MAGA). However, studies describing their effects in Chinese individuals are scarce. 450 Chinese MAGA patients were randomly assigned to receive finasteride (n = 160), minoxidil (n = 130) and combined medication (n = 160) for 12 months. The patients (...) returned to the clinic every 3 months for efficacy evaluation. And efficacy was evaluated in 428 men at treatment end, including 154, 122, and 152 in the finasteride, 5% minoxidil, and combination groups, respectively. All groups showed similar baseline characteristics, including age at enrollment, and duration and severity of alopecia (p > 0.05). At 12 months, 80.5, 59, and 94.1% men treated with finasteride, 5% minoxidil and the combination therapy showed improvement, respectively. Adverse reactions

2015 Dermatologic therapy Controlled trial quality: uncertain

15. Advocacy group spin may skew discussion on finasteride side effects

Advocacy group spin may skew discussion on finasteride side effects Advocacy group spins harms from "post-finasteride syndrome" Note to our followers: Our nearly 13-year run of daily publication of new content on HealthNewsReview.org came to a close at the end of 2018. Publisher Gary Schwitzer and other contributors may post new articles periodically. But all of the 6,000+ articles we have published contain lessons to help you improve your critical thinking about health care interventions (...) . And those will be still be alive on the site for a couple of years. 6093 Posts Menu August 12, 2015 Advocacy group spin may skew discussion on finasteride side effects Posted By Categories , , Tags , , , The following is a guest post by Dr. Richard Hoffman, a long-time story reviewer who’s been helping us knock down inflated claims from drug and device companies for years. This time, he’s raising questions about the harms attributed to a drug and whether the messages about those harms are evidence-based

2015 HealthNewsReview

16. Finasteride: rare reports of depression and suicidal thoughts

Finasteride: rare reports of depression and suicidal thoughts Finasteride: rare reports of depression and suicidal thoughts - GOV.UK GOV.UK uses cookies to make the site simpler. Search Finasteride: rare reports of depression and suicidal thoughts We have received reports of depression and, in rare cases, suicidal thoughts in men taking finasteride 1 mg (Propecia) for male pattern hair loss. Be aware that depression is also associated with finasteride 5 mg (Proscar). Published 24 May 2017 From (...) : Therapeutic area: , , Contents Advice for healthcare professionals: since finasteride has been marketed there have been a number of spontaneous adverse drug reaction reports suggesting a possible link to depression, and in rare cases, suicidal thoughts advise patients to stop finasteride 1 mg (Propecia) immediately if they develop depression and inform a healthcare professional be aware that the product information for finasteride 5 mg (Proscar) already lists depression as a possible adverse reaction

2017 MHRA Drug Safety Update

17. What are the long-term effects of taking Finasteride 1 mg daily for male-pattern baldness? If there are none known, are there any potential theoretical problems with this drug taken for many years?

What are the long-term effects of taking Finasteride 1 mg daily for male-pattern baldness? If there are none known, are there any potential theoretical problems with this drug taken for many years? What are the long-term effects of taking Finasteride 1 mg daily for male-pattern baldness? If there are none known, are there any potential theoretical problems with this drug taken for many years? - Trip Database or use your Google+ account Turning Research Into Practice ALL of these words: Title (...) @tripdatabase.com What are the long-term effects of taking Finasteride 1 mg daily for male-pattern baldness? If there are none known, are there any potential theoretical problems with this drug taken for many years? We were unable, using TRIP and Medline, to identify evidence considering finasteride for taken for alopecia beyond 5 years; the reference for this particular study appears below (1). It concluded: “Finasteride was generally well tolerated and no new safety concerns were identified during long-term

2006 TRIP Answers

18. finasteride relation with male osteoporosis

finasteride relation with male osteoporosis finasteride relation with male osteoporosis - Trip Database NEW! Google+ Liberating the literature ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top search box and pressing the search button. An example search (...) . For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com finasteride relation with male osteoporosis Answered Follow us: © 2020 Trip Database Ltd. company number 04316414. Trip is proud to be made in the UK.

2012 TRIP Answers

19. Is male osteoporosis a side effect to finasteride in the teatment of a 26 years old man because he has alopecia(loss of hair)? thanks

Is male osteoporosis a side effect to finasteride in the teatment of a 26 years old man because he has alopecia(loss of hair)? thanks Is male osteoporosis a side effect to finasteride in the teatment of a 26 years old man because he has alopecia(loss of hair)? thanks - Trip Database NEW! Google+ Find evidence fast ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words (...) as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news. For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com Is male osteoporosis a side effect to finasteride in the teatment of a 26 years old man because he has alopecia(loss of hair)? thanks Answered Follow

2012 TRIP Answers

20. Finasteride for androgenetic alopecia is not associated with sexual dysfunction: A survey-based, single-center, controlled study. (Abstract)

Finasteride for androgenetic alopecia is not associated with sexual dysfunction: A survey-based, single-center, controlled study. The occurrence of sexual dysfunction side effects associated with finasteride use in men with androgenetic alopecia (AGA) is thought to be less prevalent than is publicized. There is a need to investigate sexual dysfunction among finasteride users with population-based controls.To evaluate presence of sexual dysfunction in men using finasteride or not using (...) finasteride.Adult men visiting a dermatologist's office for any reason were asked to complete a survey including a modified version of the Arizona Sexual Experience Scale (ASEX) to assess presence of sexual dysfunction with and without finasteride use.Data from 762 men aged 18 to 82 was collected; 663 finasteride users and 99 non-finasteride users. There were no significant differences between finasteride users and non-user controls in reporting sexual dysfunction using the ASEX scale. Regression analysis

2019 Journal of the European Academy of Dermatology and Venereology